Sirdás sisdollui
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Giella
Buot deaivamat
Bajilčálus
Dahkki
Fáddá
Hildobáiki
ISBN/ISSN
Fáddágilkor
Viečča
Aiddostahtton
How best to describe the risk...
Čujuhandieđut
Deakstadieđáhus
Sádde šleađgaboasttain
Čálit
Doalvvo čujuhusa
Doalvun: RefWorks
Doalvun: EndNoteWeb
Doalvun: EndNote
Bissovaš liŋka
How best to describe the risk of meningococcal B infection?
Bibliográfalaš dieđut
Váldodahkkit:
Sadarangani, M
,
Bettinger, J
,
Scheifele, D
Materiálatiipa:
Journal article
Giella:
English
Almmustuhtton:
2013
Oažžasuvvandieđut
Govvádus
Geahča maid
Bargiidšearbma
Geahča maid
The impact of the meningococcal serogroup C conjugate vaccine in Canada between 2002 and 2012.
Dahkki: Sadarangani, M, et al.
Almmustuhtton: (2014)
Profile of Serogroup Y Meningococcal Infections in Canada: Implications for Vaccine Selection
Dahkki: Nicole Le Saux, et al.
Almmustuhtton: (2009-01-01)
Serogroup B meningococcal vaccines-an unfinished story.
Dahkki: Sadarangani, M, et al.
Almmustuhtton: (2010)
Meningococcal disease and vaccination in North America.
Dahkki: Pollard, A, et al.
Almmustuhtton: (2001)
Epidemiology of meningococcal disease in north america.
Dahkki: Pollard, A, et al.
Almmustuhtton: (2001)